Synaffix is eligible to receive an upfront payment, milestone payments as well as royalties on potential future commercial sales AMSTERDAM–(BUSINESS WIRE)–Synaffix B.V., a biotechnology company ...

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Application Delivery Controllers (ADCs) Market - Product Types, Company Types and Industry Sectors" report has been added to ResearchAndMarkets.com's ...

Mycenax Biotech and Spera Pharma collaborate to streamline ADC drug substance and drug product manufacturing services: Taiwan Tuesday, September 16, 2025, 16:00 Hrs [IST] Mycenax ...

The collaboration will combine Synaffix’s exatecan-based tech with Qurient's CDK7 inhibitor for solid tumour treatments.

Renesas has come out with a new MCU group for high-end motor control designated RA8T2. Based on a 1 GHz Arm Cortex-M85 ...